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INTRODUCTION
What I would like to do today is give you an overview of the state of science of dioxins

and health effects. What I am going to talk about first is the effect of dioxin itself. Later on

I will return to the issue that dioxin is but one of a family of chemicals and, if you really
want to understand the risk out there, we need to look at the aggregate of all of them
together. But the important thing again is that you have a planar molecule with halogens
off to the side. I would like to stress that most of the information we have, has to do with
the chlorinated molecule, but the brominated molecules are just about as equally toxic and
we know almost nothing about them, and almost no environmental monitoring has been
done to determine whether they are really out there or not.

Some properties of dioxin are relevant to its persistence and its bioaccumulation in the

environment, and why we have a problem with it. It is insoluble and is highly
bioaccumulated in food chains. It s very insolubility is a real issue from a research and
regulatory standpoint when the standard procedure concerns how much is in the water,
whereas in fact there is almost none of it in the water itself. There is a very low vapor
pressure which means that it does not volatilize very much.

EXPOSURE PATHWAYS
How are people exposed to dioxin? Food is the major source, except for some major
industrial accidents where there might be some inhalation of dioxin or some skin absorption. Essentially greater than 95% of our exposure is by the food we eat, primarily meat,
fish and dairy products. Now a lot of the attention has focused on the concentrations of
dioxin in fish, so that may be higher than the concentrations in meat and dairy products.

But in the American diet, at least up until the present time, most Americans do not eat as
much fish as they do dairy products. So we have approximately equal amounts of exposure from fish as from dairy products. There may be susceptible subpopulations who do
eat a large amount of fish who will get more than the average exposure to dioxin.
1

SOURCES
Dioxin gets into the food chain by bioaccumulating in organisms in the food chain. How

does it get into the food chain environment? Some dioxins are directly eliminated into
water, for example, from pulp and paper mills. Most dioxin is released directly to the
atmosphere and is subsequently distributed worldwide through atmospheric transport.
Dioxin is very sticky, it binds to particles, is picked up on dust particles in the winds and
is blown around. Nowhere in the world today is free from dioxin. This is a worldwide
contaminant and can be found, with sensitive analytical techniques, even in the most
remote places on earth.
When was dioxin first found in the environment, and when did it start to accumulate?

Some chemical companies have been trying to convince us for a long time that dioxin has
been around since the beginning of time, and that it is a product of forest fires and volcanic activity. Prior to the onset of heavy uses of chlorinated organics in industry, which
really commenced about 1930, levels were extremely low, based on analysis of sediment
samples. People have done analyses of Egyptian mummies from more than 2,000 years ago
and frozen Eskimos from northern Canada and the levels are below the detection limit.
Dioxin is a product of the modern industrialization.
Other than forest fires and volcanos, what are the other major sources? I think it is a point
to remember that, unlike polychlorinated biphenyls (PCBS), dioxins and dibenzofurans
have no known industrial use and they were never made for any purpose. They are

contaminants of industrial processes involving certain organic compounds and chlorine.

They are produced by lowtemperature combustion at between 300° to 400° degrees centi
grade. To destroy dioxins, you have to go to over 12000 centigrade. But you can form them
at combustion temperatures characteristic of wood burning in wood- burning stoves. In
addition, dioxin is a product formed by the chlorine bleaching of paper and pulp products. The paper industry has been very responsible in decreasing their use of chlorine

bleach, and thereby tremendously decreasing their input of dioxin and dibenzofurans into
the environment. Of course, that is after 50 years of heavily contaminating the sediments,
which give us a long-lasting problem.

What are the other sources of dioxins? In the US. Environmental Protection Agency (US.

EPA) dioxin reassessment, there was an attempt to use total mass balance equations to
determine where the dioxin is coming into the environment. A number of environmental
monitoring studies indicate that the levels do not appear to have declined since the mid to
late 19805. This suggests that we still have inputs as well as outputs, and that we are in a
pseudo steady state. In the Great Lakes, there was a peak of dioxins in the early 703 and
since then levels came down until about 1987. In the U.S., the major new sources of
dioxin appears to be hospital incineration. In Germany it appears to be municipal waste
incineration. It is not a major source here because we use landfills but, if we switched to
municipal incineration, it may become a major source in the US. If anyone knows about
hospital waste incineration, they are totally unregulated and they burn at very low temperatures, they have tremendous amounts of chlorinated plastics, and therefore lots of
dioxin are potentially emitted from them. Diesel exhaust also appears to be a source of
dioxin. Metal smelting and refining appears to be another source, but we really don t have
a good mass balance. In summary, we can account for about 50% of the new input into
the environment, and we are uncertain where the rest is coming from.

EFFECTS
A typical toxic substance goes into the body and kills cells, or does one particular thing.
In contrast, dioxin does a lot of things and should be considered as a hormone. I don t

know what it is a hormone for, in terms of the natural sense. Hormones go into the body
and they have different effects on different tissues, they can have different effects at
2

different stages of development of the tissue, and they can have different effects on differ
ent species. I think we can say the same thing about dioxin. So you see a great deal of
tissue specificity, developmental stage specificity, or age specificity, or species specificity
1n response.

At very high doses, in all species we have looked at, dioxin causes death. But, again, it is

not your typical pesticide kind of death, where you know you give a lot to the animal and

it goes four legs up in the air immediately. Death is usually preceded by a wasting syn-

drome, the animals can easily lose 50% of their body weight before they die and, depending on the animal, the time to death varies. So it takes guinea pigs about two weeks, mice
take about three weeks, so do rats approximately, monkeys take about six weeks to die, for

example. It is an inexorable process. If the level of dioxin administered to the animal,

either acutely or following repeated exposure, once they reach a certain body burden, it is
like a switch is thrown and the animal will, approximately x number of weeks later, die.
We really don t know what they die of. You can, for example, feed the animal and prevent
the wasting, and they still die. 80 it is not just because they used up their body glycogen.
The highest levels that we know that people were exposed to, would have been lethal in

guinea pigs, but they are, at least in the order of magnitude or more, lower than the levels
that would kill almost any other mammalian species. 80 I think that the reason we have

not seen wasting or death in people is we may not have had high enough exposure, and
that is not an experiment I think we are going to try.

At levels below that where you see wasting, you can see effects on the lymphoid tissues
and you actually have loss of the thymus and spleen and at slightly lower levels, and in
the adult male you can have atrophy of the testis. But, again, these are all relatively high
dose effects. Effects on the liver -- there are some differences in different species but, in
general, you see enlargement of the liver, you see accumulation of fat in the liver. In some
tissues, you have hyperplasia, which is a proliferation of cells. The tissue actually gets
bigger from having more cells, and this occurs in the lining of the gastro intestinal tract, it

occurs in the lining of the urinary tract, and it occurs in the bile duct, which comes from

the liver.

In other kinds of cells, instead of getting hyperplasia, which is an inappropriate proliferation of cells, you get squamous metaplasia, which is an inappropriate differentiation of
cells. It is not that an eye turns into an ear, but in fact one type of cell turns into another
type of cell. It starts behaving differently. So, one of the classic kinds of symptomatology
that we see, not only in monkeys for example, butalso in humans, is metaplasia of the
meibomian glands of the eye. Now, meibomian glands are little glands at the base of your
eyelid that secrete very small amounts of uid. With exposure to dioxins, these actually
change and start producing waxy exudates on your eye that makes vision very difficult and

this is a complaint of people who have had very high levels of dioxin exposure. They also
complain'of problems with hearing. There are glands that line your ear canal which are call
the ceruminous glands and these also undergo an inappropriate differentiation and start
producing earwax. These are not the normal glands that produce normal earwax. It might
be possible to monitor exposed people by collecting some of their earwax and measuring
the concentrations of dioxin and related chemicals in the earwax. It will be a little hard to
do mass balance equation to calculate their whole body burden, but it might be an accessi
ble source of tissue where you could find out whether there had been exposure.

Chloracne has been the hallmark of dioxin toxicity. This is not the ordinary teenage acne,
but a very, severe persistent form of cystic acne. People who had been exposed over 40
years ago to dioxins in industrial accidents are still having active Chloracne, not limited
just to their face and back, but all over their bodies. It is characterized by hyperplasia,

which is a proliferation of cells, by hyperkeratosis, which is an altered differentiation of
the cells, and by changed pigmentation. It is a very severe condition. You could say it is
just acne, but obviously it has changed the lives of these people.

Dioxin is a potent teratogen in a number of species in that it causes actual gross structural

abnormalities, cleft pallet, and hydronephrosis in mice. In other species, it causes much

more subtle developmental effects. Effects that, until the last couple of years, we were not
really aware of, because they are the kind of effects that you do not see in a standard
teratology study. In a standard teratology study, you dose animals during organogenesis,
which is the major period of differentiation of the different organs and tissues, and then

you sacrifice them just before they would normally be born. The developmental effects we

are studying now in fact are things that you do not see until the animal reaches puberty,
and then there are alterations in the sexual functions and reproductive behavior of the
animals. So, if you kill the animals at birth, you are not going to see what is going to
happen.

I will talk a little bit more about cancer. Dioxin appears to be a carcinogen in fish, rodents
and other mammals, including humans. But dioxin can also modulate the immune system
resulting in an inability to fight disease. It is a very powerful immunosuppressant. It can
also upregulate the immune system so that you start becoming hypersensitive, start developing autoimmunity and allergies. Depending upon the stage of the animal and the
species, sometimes you observe immunosuppression and in other cases you observe

upregulation.

BIOCHEMICAL EFFECTS
Dioxin causes a wide variety of changes in enzyme levels and causes biochemical effects

(Table 1). There has been some discussion about whether these changes represent adverse

effects or just biological responses. I think many of them can be considered as biomarkers

of the potential for other effects to happen. These changes in enzyme levels, including

increases and decreases in the synthesis, leads to alteration in metabolism of both endogenous and foreign compounds. For example, it affects the way we handle glucose metabo-

lism, induces cytochrome P4501A1 and P4501A2 and regulation of other kinds of
enzymatic activity.

TABLE 1: BIOCHEMICAL EFFECTS OF TCDD:
ENZYME INDUCTION

TABLE 2: BIOCHEMICAL EFFECTS OF TCDD:
MODULATION OF HORMONES AND RECEPTORS

Cytochrome P4501A1

Androgens

Cytochrome P4501A2

Estrogens

DT Diaphorase

Estrogen Receptor

Glutathione S Transferase

Glucocorticoids

Aldehyde Dehydrogenase

Glucocorticoid Receptor

Omithine Decarboxylase

Insulin

Tyrosine Kinase(s)

Gastrin

Terminal Deoxynucleotidyl Transferase

Thyroid Hormones

Phosphonenolpyruvate Carboxykinase

Melatonin

Plasminogen Activator Inhibitor-2
Results in Altered Metabolism

Results in Altered Homeostasis

Dioxin modulates many hormone

Systems and their receptors (Table 2).

It affects. thyroid, gastric hormones and
melatonm, wh1ch IS a product of the

TABLE 3: BIOCHEMICAL EFFECTS OF TCDD:
MODULATION OF GROWTH FACTORS AND

RECEPTORS
Vitamin A

pineal gland involved in the circadian

rhythm. It affects estrogen, androgens,
glucocorticoids and insulin. Dioxin
causes the modulation of growth

Epidermal Growth Factor
Transforming Growth Factor (1

factors and their receptors including,

Epidermal Growth Receptor Factor

for example, Vitamin A. By affecting

hormone systems, you alter the

Transforming Growth Factor B

homeostasis of the animal and switch

how the animal behaves. For example,
dioxin can act both as an anti-estrogen

Tumor Necrosis Factor on
Interleukin 1 B

by blocking estrogen activity in the
breast or the uterus, andnin other

proto_oncogene Cellular_RAs

tissues it may act more llke an

Prom-oncogene Celll ar-ERBA

estrogen. Dioxin causes decreases in
circulating thyroid hormones in, for

Results in Altered Growth and Differentiation

example, rats, but it causes increasing

levels of circulating thyroid hormones

in mice. I think we have to be very
careful when we talk about these effects to realize again that hormones are very carefully
modulated, and the way that we maintain homeostasis in our body is by having a balanced
level. So, if you perturb the level, either by increasing it or decreasing it, you are putting
yourself at risk for problems.

Many different molecules are involved in controlling the activity of cells (Table 3). But
there are growth factors, such as epidermal growth factor, which tells cells to divide, and

there are factors like transforming growth factor beta that tells cells to stop dividing. There
are growth factors like insulin growth factor, which is involved in glucose metabolism and
in many other functions in the body. Dioxin modulates the activity of many of these,

leading to altered growth and differentiation. Dioxin is therefore a very potent growth
dysregulator.

MECHANISM OF ACTION
How does dioxin cause these biological effects? One thing I want to impress you with is
that the mechanism of action is much more complicated than we thought. A couple of
years ago, we thought that TCDD came in and bound to a protein called the Ah receptor

and that went on into the nucleus and interacted with DNA to lead to changes in the
expression of genes and of protein. We know now that it is much more complicated. The

way that the Ah receptor functions, it is never present as an isolated protein (Figure 1).
Its action is controlled by other proteins, so that the Ah receptor binds to two molecules of
the proteins called heat shock proteins. Heat-shock proteins were first identified by
raising the temperature of an animal, and observing changes in these kinds of proteins.
These proteins control the ability of the receptor to bind dioxins. Then there is another
protein here, which has been identified only by its molecular weight. I am going to come

back to this later. We call it p50, but we really don t know what it does. We have an

hypothesis but no tests. We have this complex of four proteins binding dioxin, and then
something happens. I leave this purposely vague, other than to say we lose the heat shock
proteins, we lose p50, but gain another protein which, at this point in time, is a protein
called arnt. This complex -- and we don t know whether this forms in the cytoplasm or in
the nucleus - functions in the nucleus, so that the complex that actually alters genetic

activity is composed of two proteins, as well as TCDD. Then the dioxin can be recycled

back. Heat-shock proteins are two molecules and this is really a family of proteins, and
5

TCDD

.

) .

Ah receptor

/

and p50

Heat-shock
proteins

p50 .

Heat-shock
proteins

Nuclear

((

\\

\\
\

membrane

1

n

/

[I

//

/ //

/

DEGRADE
imRNA

)

Figure 1. Model of Mechanism of Action of TCDD and Ah Receptor.
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they are developmentally regulated. You have the possibility that, at different stages, these

may function differently in controlling the ability of the receptor to bind the ligand.

There is the possibility that amt, the second protein which is actually involved with the

DNA binding, is part of a family of proteins. TCDD bound to a receptor can interact with
amt 1, amt 2, amt 3, amt N to form this heterodimer, the two protein complex. Each of

these will only recognize one specific gene. So we have multiple levels of interaction
going on here. We have multiple transcription factors, multiple DNA recognition sites,
and we also know that even the Ah receptor, which at one point in time we thought was

the product of a single gene, has multiple alleles of that gene so that there are Ah receptors

that are slightly different sizes. We do not know yet about the specificity of the receptors
and whether the receptor for the protein with a size of 106 kilodaltons will accepted the 97

kilodalton protein, in addition there is a 110 kilodalton receptor. We do not know whether
or not these have any functional implications but at least there is that possibility. The
point is we are not dealing with a simple system. This is really quite complicated.

To make it a little more complex, Figure 2 is a hypothetical schematic of the two ways that
the dioxin Ah receptor complex functions to alter the genetic activity of the cell. First, it
changes it so that you have more protein synthesis or less protein synthesis. And this is
what has been demonstrated and what people have spent most of their time looking at.
That, in fact, TCDD binds with this complex, which then falls apart and the dioxin
receptor, plus that amt protein, goes into the nucleus, and alters transcription and gene

expression. Second, this p50, which I told you about and we really don t know what it is,

there is at least an hypothesis that this protein is a tyrosine kinase. These are proteins that
put phosphate groups on tyrosine residues. Tyrosine is an amino acid in proteins, and
when you phosphorylate proteins, you affect their activity dramatically. With some recent
studies from a number of laboratories, including our own, we can show tyrosine kinase
activity is activated minutes after dioxin exposure. Things are happening too quickly to
involve changes in what is going on in the nucleus. They involve changes that are going
on at the point of contact. We know also that some of the proteins that are phosphorylated

by tyrosine kinase in response to dioxin are proteins that control the movement of cells

through the cell cycle. Here we have a direct tie in between a very rapid effect of dioxin,
which clearly requires the receptor because it acts as a regulator of this protein. When this
protein is bound to the receptor, it can t phosphorylate other protein. When you release it

from activity, it now goes on and does its thing. One of the critical differences about

dioxin as compared to, for example, compounds in broccoli, cauli ower, and other foods
we eat that also bind to this receptor, is that those compounds are very rapidly metabolized and gotten rid of. So you have a very short-lasting effect. The problem with dioxin
is that you have a persistent effect. Dioxin. comes in, it binds its receptor, and it ties it up.
So you get a constant signal from the nucleus to make more protein, and you have a constant phosphorylation going on. Usually phosphorylation events are very tightly regulated. They are usually very much on-off, and now you locked the switch. I think the

whole idea of the persistence of the dioxin activity is an important one to think about
when we try and understand what the compound is doing.

So what I have shown you is that this binding to the Ah receptor is necessary for the
effects of dioxin, it is the first step, but it is clearly not sufficient. Many other things have
to happen subsequent to binding to the receptor.
I think what you really have is a biological amplification of these responses and it occurs
by a cascade of growth factors and hormones and the term that is used inthe literature

now when we talk about steroid hormones, the estrogens, the gluco-corticoids, the

progesterones, is that you have combinatorial complexity. What that means is that you
have a complicated network -- nothing is linear -- everything is interacting, and that is
exactly what is happening with dioxin. It is almost like dioxin is going into the middle of
this network, and sending out signals in all directions.

COMPARATIVE TOXICITY
There is a wide variation in acute toxicity of TCDD to adult mammals (Table 4). The

guinea pig dies a week or so after being exposed to dioxin, whereas hamsters survive until
you get to very high doses. You have approximately 3-5,000 fold differences in sensitivity.
For many chemicals this is highly unusual. For something that functions like a hormone,
this is not totally unexpected. But the point that I want to gather is that, while guinea pigs
are exquisitely sensitive, and I am going to stress that these are adult guinea pigs, and
adult hamsters are very resistant, most mammals tend to cluster in the neighborhood of
100 micrograms per kilogram as approximately the lethal dose. 80 while the guinea pigs
and the hamsters are outlyers for this response, most animals are similar. I stress the point
about adult hamsters versus adult guinea pigs because if you look at hamster embryos or
fetuses, they are essentially equisensitive to guinea pig embryos. If you look at rat em
bryos, they are essential equisensitive. There is something about the adult hamster that

makes them resistant to TCDD, but the embryo responds at the same concentration as lots
of other species.

With respect to dioxin, people react

TABLE 41 ACUTE TOXICITY 0F TCDD
SPECIES
Guinea pig
Mink
Rat

Monkey
,
Rabblt
Mouse

Dog
Hamster

similarly to animal responses. Biology is

inherently conservative and things tend to
work the same way in many species.
There is a large amount of data showing,
for example, that changes in biochemical
properties such as enzyme induction, in
some hormonal states and in growth

LD (pg/kg)
0'6 _ 2.5
4
22 _ 320

factors occur at similar body burdens in
animals as they do in people. For exam-

<70

ple, in the ongoing occupational study
conducted by National Institute of Occupational Safety and Health (NIOSH)

115'275
114-280

looking at workers who were exposed to
dioxin, these adult males are showing
decreases in the levels of their circulating
testosterone at body burdens very similar

>100 ' <3,000
1 150 _ 5 000

to the body burdens in adult rats. In
immunotoxicity testing, human

lymphocytes and cultured cells respond to the same concentration of dioxin in the media
as mouse and monkey cells. In terms of developmental toxicity based on organ culture

you find similar responses at similar concentrations of TCDD. For example, if you take out
the embryonic palate of a rat and the embryonic palate of a human, put them in culture
and expose them to the same concentration in the media, you get a similar response.
Similarly, the body burden associated with chloracne in people is essentially the same as
the body burden causing chloracne in monkeys, in hairless mice, or in rabbit ears. Ani
mals with a lot of hair -- like regular mice and regular rats -- do not develop chloracne, but

hairless mice do and the body burden there is essentially the same. Cancer appears to
occur at similar body burdens in animals as in humans.

SUBTLE DEVELOPMENTAL EFFECTS
I will just mention some really recent data on subtle developmental effects that you would
not see if you only looked when the animals were born. Dick Peterson at the University of
Wisconsin is doing some very important mammalian work. A year ago he reported that if
he treated pregnant rat dams towards the end of gestation with a very low level of dioxin,
as low as 65 nanograms per kilogram, it resulted in demasculinization and feminization of
the male offspring. Most of these changes were not detectable until they reached puberty.
8

We have since repeated that study, not only with his kinds of rats, but also in another
strain of rats. We have also looked at hamsters, and we get basically the same result. We

see decreased sperm count, altered sexual behavior, and shortened genitalia in these male
rat pups. We have looked at both female rat and female hamster pups and we see even
more dramatic changes in the females, where we see hypospadias, which is where the
urethra, instead of emptying in a separate opening at the top of the clitoris, actually empties into the vagina. We see complete clefting of the clitoris, and a cleft being maintained

all the way down to the vagina. In the rats, we see delayed vaginal opening and, in some

cases, no vaginal opening. In the hamsters we cannot even find an external vagina in
some cases. Clearly, the animals with no vaginal opening are not going to be fertile.
Although these animals appear to be cycling perfectly normally and the ovarian-pituitary

axis appears to be functioning properly, we do not really understand the mechanism of

what is going on and we are trying to explore it.

These are very concerning events and Dr. Guo from Taiwan, who is one of the principle

investigators on the Yucheng cohort, visited my lab two days ago. This is the PCB rice oil
poisoning in Taiwan in 1979, where about 2,000 people unfortunately cooked with rice oil
that was contaminated with PCBs that were themselves contaminated with the
polychlorinated dibenzofurans. The children born following this episode have been
followed for the past 8 13 years, that is the age of the kids now. When they were first born
they were reported to have what was called ectodermal dysplasia syndrome, which included all sorts of pigmentation problems, problems with their nails and dentition, and
they were small in stature. When they did development milestones, these kids were

developmentally delayed. They have continued to follow these kids. Their IQ is shifted
about five points down from the rest of the population, and this has been maintained as
they have grown up. It is not something they have outgrown. The children continue to be
shorter in stature than matched controls and as the boys approach puberty, and some of
them are now between the ages of 8-13, the ones who are 10, 11, 12 and 13 are apparently

having problems with their genitalia. This is very new data, some of it will be presented
this fall at the Dioxin Meeting, but it is very compatible with the data that we are seeing in
the experiments.

CANCER
Dioxin is a carcinogen [Table 5). There are at least 18 studies in mammals, all of which

are positive. You may have heard that dioxin is a tumor promoter, and not a carcinogen,
because it does not directly interact with the DNA. I think we start to dance on the heads
of pins because When I am saying dioxin is a carcinogen here, if you feed animals in longterm studies without adding any known initiator, dioxin by itself still causes an increase
in tumors. It does not cause only one type of tumor, it causes tumors at multiple sites. It
causes it in both males and females, and
TABLE 5; DIOXIN Is A CARCINOGEN;

it has been detected in rats, mice and

hamsters. In addition, work from the

ANIMAL STUDIES

US. EPA laboratory has indicated that

OMammals - 18 studies

dioxin causes increases of tumors in

medaka, at multiple sites and short
latency and at high incidence.

All positive
Rats, mice, hamsters

There are three recent human epidemiology studies [Table 6) which, I believe,

deserve extra weight when we look at the
dioxin epidemiology literature. Prior to

these studies, there were probably equal

numbers of studies that said, yes, dioxin
does cause tumors in people and, no, it
doesn t. The advances that these three

1

.FiSh

Medaka

Multiple sites

Short latency
High incidence

studies (Fingerhut et al. 1991, Manz et al.
TABLE 6 5 DIOXIN IS A CARCINOGEN

HUMAN EPIDEMIOLOGY

Three recent occu ational cohorts

p
Zober et al. 90

Fingerhut et al

91

1991, and Zober et al. 1990)* have are that

they have blood levels for the cohorts. So
they can actually validatetheir exposure in
, ,
_
_
.
,
then industrial hygiene matrlces w1th serum
levels of dioxin. In that case you find an
increased standardized mortality ratio

related to exposure to dioxin, especially in

Manz et (IL 91
_
'Incréased Standardlzed mortahty

the people who were exposed long term;
people with at least 20 years of exposure.
This was a generalized tumor response. I

.Generalized tumor response

stilbestrol (DES) that specifically caused

ratlos related to exposure

think you are all familiar with diethyl

vaginal adenocarcinoma in young women.
The specificity of the lesion is why we were
able to find out that this was a problem. If
you have something that causes a generalized increase in cancer, it is very hard to pick up.

There is a suggestion from two of these studies that there may be an increase in lung

tumors. Well, with the background as high as it is in lung tumors, it is very hard to pick

up a small number of extra cases. But in fact these studies are all very compatible with

each other, showing that high levels of exposure to dioxin are associated with an increase

in cancers overall.

There is another study that will be published in the September issue of the American
[ournal of Epidemiology, based on the Seveso cohort. Seveso was a town in Italy, and in
1976 there was an explosion at a trichlorophenol plant and the area around it was highly
contaminated. The serum levels in some of those people were the highest that we have
ever seen. Until now there has been a suggestion in a report published in 1989 that there
might be a increase in cancer, but it was just too soon, and the numbers were too small.
This paper in press now actually demonstrates, based on cancer registry data in that area
of Italy for 11 years since the explosion, there are very significant increases in multiple
types of tumors in that population. Now that you think it is all bad, there is also a decrease in breast cancer. Remember I told you dioxin is a hormone, and it may increase
some things and decrease other things. The decrease in breast cancer, by the way, has
been reported in animal studies. In this report on the Seveso study to be published, the
increase is in both males and females, and again at multiple sites. I really find it hard to
accept the negative, or the null hypothesis. To me, the data is overwhelming that dioxin
has the potential, at least at high doses, to result in cancer in people.

*Fingerhut, M.A., W.E. Halperin, D.A. Marlow, L.A. Piacitelli, P.A. Honchar, M.H.
Sweeney, A.L. Greife, P.A. Dill, K. Steenland, and AJ. Suruda. 1991. Cancer Mortality in

Workers Exposed to 2,3,7,8 tetrachlorodibenzo p-dioxin. The New England journal of

Medicine. 324:212 218.

Zober, A., P. Messerer, and P. Huber. 1990. Thirty-four year mortality follow-up of BASF
employees exposed to 2,3,7,8-TCDD after the 1953 accident. International Archives of
Occupational and Environmental Health. 62:139-157.

Manz, A., J. Berger, ].H. Dwyer, D. Flesch-Ianys, S. Nagel, and H. Waltsgott. 1991. Cancer
mortality among workers in chemical plant contaminated with dioxin. The Lancet.
338:959-64.
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TABLE 7: DOSE/RESPONSE RELATIONSHIPS

If we look at the dose response

relationships for d10X1I1 (Table x),

LIGAND BINDING

BIOCHEMICAL ALTERATIONS

mteraction w1th the receptor w1ll
occur at the lowest concentration.
The activation of the receptor interacting w1th DNA may requlre addi-

IMMUNOTOXICITY
DEVELOPMENTAL DEFECTS
CHLORACNE

tional steps, and then all these other

CANCER
effects including enzyme inductlon,
1mmunotox1c1ty, developmental
DEATH
effects occur at much lower levels
_______'____ >
than, for example, chloracne or
INCREASING DOSE
cancer. You have to have very hlgh
levels of exposure to diox1n before
you see chloracne. In cancer, in order
to detect an increase in tumors, you have to have evenhigher doses again. With the
immunotoxicity, one thing I should mention, is that in the Taiwan cohort, the children, not
the adults, are reported to have elevated incidences, not only of respiratory infections, but
also otitis, ear infections. In the northern Quebec Inuit population exposed to very high
levels of PCB relative to the general population, children also have very high incidences of
respiratory infections and otitis, and also a very decreased rate of take of vaccinations. All
which would be at least compatible with the effects on the immune system.
A recent report presented at the American Society of Gynecology has indicated that
exposure to dioxin resulted in endometriosis in TCDD-exposed rhesus monkeys, many
years after the cessation of exposure. These monkeys were part of a cohort that was being
studied at the University of Wisconsin. Seven years after the termination of exposure, one

of the higher dose monkeys died after evincing severe pain and an autopsy revealed that it

had fulminating endometriosis. Since then, one other monkey has died, and it died of the

same cause. In monkeys, endometriosis can be fatal, though it is not fatal in humans.

There was a Canadian study out of Health and Welfare Canada which had reported, in

abstract form, a suggestion of increased endometriosis in monkeys exposed to Arochlor
1254, which is the PCB with the highest concentration of dioxin like PCBs in it. Because
of all these findings, the Endometriosis Association paid for some veterinarians and some
gynecologists to do laproscoptic surgery on all the monkeys. There were controls, monkeys exposed to five, and monkeys that had been exposed to 25 parts per trillion of dioxin

in their diet and they had been exposed for four years, but that exposure had been termi-

nated 10 years before this laproscoptic examination. There was a dose-related increase in
both the incidence and severity of endometriosis, as compared to not only the control
monkeys from this study, but to their historic controls from their monkey colony, which
suggesinvolves something like 300 monkeys. There are now at least two studies that are
and
monkeys
these
in
osis
endometri
of
incidence
increased
an
tive of an association, or
.
application
human
significant
fairly
has
it
there is a possibility that

1
_

5
3

RELATIVE POTENCY RANKINGS
Dioxin is but one of a family of compounds including the naphthalenes, the

dibenzofurans, the biphenyls, both the 320- and azoxybenzenes and then there were
additional compounds. Remember, naphthalenes were commercially produced between
World War I and World War II, and the halowaxes were used to finish the nice wood
g
floorng on your ships and, in fact, there were numerous incidences of chloracne occurrin
that
in some of the workers. These compounds are probably the major actors though,
receptor and
when they are halogenated in the lateral positions, can interact with the Ah
cause the same spectrum of biological responses.
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TABLE 8: RELATIVE POTENCY
(CLEFT PALATE)

TCDDA

1.000

TBDD

.235

B

TCDFA
TBDFB

These chemicals all act by the same

mechanism, and we should be able to assign
them relative potency rankings. The toxic

equivalency scheme is a scheme of relative
potency ranking. These compounds are

considered as if they were a dilution of

.049
.100

TCDD. So you weight them and if you
assign TCDD a value of. 1, you can see that.
the brommated d10x1n IS about 1/4th as tox1c

1,2,3,7,8-PEBDF

.026

as TCDD itself. The tetrachlorodibenzofuran

1 2 3 7 8'PECDFA
2,3,4,7,8 PECDF

'004
.095

is only l/20th as toxic despite looking like
TCDD and binding very tightly to the
receptor. It is much less persistent than

'

'
.010

mammalian systems, so the exposed animal
can get rid of it, since metabolism for these

2 3 4 7 8 PEBDFB
HCDF"

HBNC

2,3,4,5,3 ,4 -HCBA
ABirnbaum et al., 1987
BBir'nbaum et al., 1991

CMiller & Birnbaum, 1986

005
002

,00003

TCDD and is readily metabolized in the

chemicals is a detoxification process. The

brominated-dibenzofuran is more toxic than
the chlorinated, while for the dioxin it is the
reverse, because the brominated
dibenzofuran is harder to metabolize than
the chlorinated. You can rank these com-

pounds (Table 8) according to their relative

effect. This was done for cleft palate, and it

has been used in the development of toxic equivalency factors (TEFs) and many other
kinds of end points have also been used. For example, receptor binding I have already

mentioned. Induction of biochemical responses, like enzyme induction, and this can be
done either in the animal in Vivo or can be done in test tubes with cultured cells,
teratogenicity, effects on the skin, dermal toxicity, immunotoxicity, or tumor promotion.
All these things have been used, and looked at in total to come up with a toxic equiva
lency scheme. The US. EPA came out with interim TEFs in 1989, which I think is essentially identical to the NATO values also today being used by Scandinavian countries, and I
think Canada uses the same numbers for the dioxins and furans.
The question is, what about the dioxin like PCBs? The US. EPA is determining values for
TEFs for the dioxin-like PCBs in fish, we have been looking at them in a long term mouse

study, and Health and Welfare Canada has been looking at them in a long term rat study.
What we are finding is similar, which is that while the dioxin-like PCBs must be considered in any kind of assessment, in most cases they are not going to drive the re-assessment.
Congener No. 77 binds the receptor very well, but it is very rapidly metabolized in mammalian species and by many fish. So its in Vivo toxicity is much less than you would
predict based on something you did in culture. On the other hand, birds have very lim
ited ability to metabolize these compounds, so you want to assess the toxicity for birds,
using in Vitro tests, while for species that can metabolize it, you may want to use in vivo.
In other words, TEFs have to be applied with a certain degree of thought behind them.

Birnbaum, L.S., M.W. Harris, D.D. Crawford, and RE. Morrissey, 1987. Teratogenic
Effects of Polychlorinated Dibenzofurans in Combination in C57BL/6N Mice. Toxicology
and Applied Pharmacology. 91:246-255.
Miller, CF. and LS. Birnbaum. 1986. Teratologic Evaluation of Hexabrominated

Naphthalenes in C57BL/6N Mice. Fundamental and Applied Toxicology. 7:398 405.
L.S. Birnbaum, R.E. Morrissey, and M.W. Harris. 1991. Teratogenic Effects of 2,3,7,8-

Tetrabromodibenzo-p-dioxin and Three Polybrominated Dibenzofurans in C57BL/6N Mice.

Toxicology and Applied Pharmacology. 107:141-152.
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CONSENSUS POINTS
So, at this point, I think in the general scientific community, there are three consensus

points. In general I think the scientific community would say: i) that dioxins are growth

dysregulators that are mediated through the Ah receptor; ii) that people are sensitive to the
effects of dioxin; iii) and if you are going to look at the environmental risk from these
compounds, you need to consider all the related isosteric compounds.

DIOXIN RISK ASSESSMENT
There are two approaches you can take to estimate dioxin risks. One is to use a biologi
prefer
cally-based dose-response model, the other is to take any mathematical model. We

to put more science into the risk assessment process and develop models which are
hubased on the mechanism of action of the compound in extrapolating from animal to
evidence
man data, and from high to low dose. It is important to stress that there is no
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t
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the aquatic data and
And then there is the issue of susceptibility. In the animal data, both
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like PCBs would protect us against the non-dioxin-like PCBs. Our current dioxin exposure is somewhere in the neighborhood of maybe 30-50 parts per trillion on a toxic equiva
lency basis, derived primarily through the food. This kind of body burden of dioxins and
furans is associated with exposure to about 1-3 picograms per kilogram per day. But
nursing infants and subsistence fishermen may have higher levels of exposure.
So I think there are two views that can be looked at. The first one is, are current levels in

the environment a problem? The second is that if we do not think they are a problem,
should we worry about these special populations, the nursing infants and the subsistence
fishermen? Do the current levels have the entire population on the brink of some kind of
biological response? I am purposely vague, I am not saying adverse effect. Death is clearly
an adverse effect, but is alteration of your hormonal status an adverse effect? I am not
sure. It probably depends in what environment you find yourself. You know if your
glucocorticoid levels are already elevated and then you are stressed, you might have a lot
more problems than someone else. But are we at the level of beginning to expect responses? In fact, are there people in the population who are already experiencing subtle

health effects? I should mention that male sperm count has dropped over 50% in the last
50 years, the incidence of endometriosis in the human population has increased dramati-

cally, the age of menarche has decreased dramatically and this cannot all be accounted for
by nutritional changes. I mean there are definitely things going on there. There is a recent
suggestion that elevated levels of DDT are associated with increased incidences of breast
cancer. Are there subtle things going on? I don t really know the answer to that but, if
they are, then clearly, any increase of individual exposure would be undesirable.

U.S. EPA DlOXlN REASSESSMENT
Now, before I tell you what I think, I just would like to brie y mention the dioxin reassessment. About three years ago, there was a meeting on dioxin at the Banbury Center in
Connecticut and, when we came back from it, I was really excited. I was also real naive. I
had just joined the agency, so I wrote Erich Bretthauer a memo telling him I thought this
was an opportunity for the agency to get in front of the issue, instead of always coming in

at the rear, and that there was enough new information that had been gathered about the
effects of dioxin that we really ought to reassess its risk. In fact, Bill Reilly, a little over

two years ago, decided that we would do that and we started a multi-faceted approach

including a bioaccumulation project and an aquatic toxicity project. There are many other
parts of this reassessment. There has been evaluation of the literature, which has been
ongoing. This is a critical review of the new literature. There have been eight chapters
written, and they have been done by outside experts in conjunction with US. EPA people

as well. These were peer reviewed last September at a meeting and have been undergoing

re evaluation and updating really since that time. There is also analysis of the exposure

information. I should say there are actually eight to nine revised chapters that will be

available shortly, the exposure scenario was also reviewed last September and that has

been revised, and there are three volumes of exposure assessment. We have been looking
more closely at human tissue levels, in collaboration with colleagues at the Center for
Disease Control (CDC). We have been doing a lot of data collection, because what we

wanted to do was try to develop extrapolation models that would be biologically based.

There was some data that we felt we were missing, and we tried to identify the most
sensitive responses that we could measure and obtain better estimation of the toxic equiva
lency factors for the coplanar PCBs. All these different kinds of bench and laboratory
science have been ongoing and are feeding into a risk characterization. We had originally

hoped this would be done by now, but we have been held up by the epidemiology because

all this new information which is just coming out, for example, the paper in press about
cancer in Seveso, needs to be incorporated into the document. I think we are currently
looking at public release of drafts of these documents probably in about October, which
means that they would be taken to our external Science Advisory Board for review in
probably January or February.
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One thing we have tried to do in this reassessment is keep it a very open process. We

have done lots of public meetings. We have solicited comments from the public. If any-

body has additional comments, we are more than welcome to entertain and listen to it and
incorporate it into the process. When we go out with the draft in approximately October,
we will also hold a series of additional public meetings, probably in several regional
offices across the country so that there will be greater access, as opposed to holding those
kinds of meetings in Washington.

80, what were the results of last September s review? Well, the outside panel, at that
point, said that the body burden in the general population was at or near the level where
responses are expected to occur. I am going to editorialize, and I am not speaking for the

agency, I am only speaking for me, but this sounds to me that this has a direct impact on a

regulatory agenda. Thank you.
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QUESTIONS
David Villeneuve, Health and Welfare Canada: You have made reference to neurobehavioral
effects in connection with the Yucheng study, I believe, and PCB and dibenzofurans. Is
there any indication whatsoever that dioxins are perhaps implicated in neurobehavioral
effects?
Linda Birnbaum: Yes, there is. Prenatal exposure of monkeys appears to result inaltered
spatial memory. You can tell monkeys that they are supposed to remember where a certain
object is, and the dioxin exposed monkeys have much more trouble with this short- term
spatial memory than animals who were not prenatally exposed. Most of the Yusho and
Yucheng data on responses is purely correlative, but if you try to associate them with the
level of PCBs or the level of dibenzofurans they correlate with the dibenzofurans level
much more than the PCB level for most of those things. So we know that certain PCBs,
like some of the non-dioxin-like PCBs, are developmentally neurotoxic, but dioxin itself
also appears to have a different spectrum of developmental neurotoxicity. Clearly, the

sexual behavior effects are neurotoxic effects, but they were induced developmentally.

Gerald Rees, Ontario Ministry of the Environment and Energy:

Would you say that as a result

of the dioxin reassessment we now have a better understanding of the implications of
dioxins or are there more questions than when you started?

Linda Birnbaum: The answer is yes to both. Because if you do a good scientific study, you
always raise more questions than you answer. But I think we have learned a tremendous

amount. I personally feel that the identity between animals and humans is much stronger
than it was a couple of years ago. I mentioned the testosterone studies that have come out
of the NIOSH cohort. There are also indications that highly exposed populations, not only
the industrial workers but the small number of ranch handers from Vietnam who were
highly exposed, they also had the problems with testosterone and they also had problems
with the glucose tolerance test and an increase in diabetes, and so did the NIOSH cohort.
We don t know yet, and they are busy looking at that, whether it is Type I or Type II, Type I

being auto immune and Type II being age-associated. The ranch handers also had in
creases in circulating immunoglobulin A (IgA), which would change the immune system,
and increases in circulating lipids. Now those ranch handers come back every five years
for a followup. They were back in 92. It will probably take 2-3 years before we have the
results of that analysis. I think we are going to see a lot more information out of the
Seveso cohort in the next couple of years. If we are going to do some more epidemiology

studies, we need to look at the right population, and I don t think the right population is
adult males. I think we need to be looking at adult females and we need to be looking at
children born to women who were exposed and we need to follow those kids, especially
for when they hit puberty.

Milton Clark, U.S. Environmental Protection Agency: One of the results that is coming out now
is about the criticism of U.S. EPA s conservatism with dioxin relative to this non-threshold

linear multi-stage model. Do you feel fairly comfortable we were on the right track some
years ago, particularly when you look at the Fingerhut studies which show that when you
extrapolate from the workers studies it models pretty closely the Kociba/Dow studies?

Linda Birnbaum: You are asking me a question I am not supposed to answer. Because until the
reassessment is complete, we are not supposed to say anything. But I will say if you do
the linearized multi-stage model, you come out with a certain number and if you now do a
reference dose model, but look at the neurobehavioral or developmental effects, you come
out with the same number, actually, even lower sometimes.
Milton Clark: But the Fingerhut extrapolation of the doses fall pretty closely on the cancer
incidence.
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Linda Birnbaum: If you take the human data. Well, you can do it two ways. You can take the
Kociba data and predict the human response - what would be elevated risks - and it
comes out right in the ballpark of Fingerhut, Zober and Manz. You can take the F ingerhut
data and predict what the animal tumor incidence would be, and it comes right out. In
fact, the Fingerhut data would actually predict more tumors in animals than Kociba.
Tony Wagner, Environment Canada:

Your last slide in your off-the-record comment, do some

people take that as the first step of organized brinkmanship?

Linda Birnbaum: I m not sure I know what organized brinkmanship means.
Tony Wagner:

We are at a critical stage - either ban it or mount a massive cleanup.

Linda Birnbaum: The last slide was the conclusion of our outside peer panel. On the last day
of the peer review, they actually sat there and they listed effects, and they listed body
burdens that were associated with the effects in animals, and then they listed the body

burdens associated with effects in people. I should really stress, this is a TEQ. If all you
are worried about is dioxin, the levels of dioxin by itself, are probably not that high. But

when you look at the sum total of what is out there, that is where the body burdens may be
high enough so you might say we are having a response. Your question about ban it or not

banning it - I mean, what are you going to ban? We don t even know where half this stuff
is coming from. My feeling, and this is purely my opinion, I have actually heard industry
people say this and this is totally off the record, is that the total level of halogenated
aromatic organics in the environment is higher than they should be.

Denis Davis, Environment Canada:

Do you have the historic body burden trends?

Linda Birnbaum: That is a really good question but we don t have the information, Well, if you
go back to Eskimo mummies from around 1600, they were essentially non-detect. We

don t have the information. There is a suggestion, Larry Needham told me about a month

ago that the CDC is looking at the levels today. Some of these levels are based upon studies that were samples that were collected maybe 10 years ago, and they think the levels are
a little bit lower. But we don t have enough numbers to really firm that up.
Doug Dodge, Ontario Ministry of Natural Resources: Is there any reason to look at aboriginal
people in' a different way than we would look at the rest of the general population, in
terms of exposure and body burden? Were they lumped into that group?
Linda Birnbaum: Yes they are. We know that the Inuits in Hudson Bay have much higher body
burdens. Eric Dewailly from Quebec has actually measured PCB levels and he has done it
on a congener-specific basis and they have about 10 times the TEQ.
Doug Dodge: But could that similarly be a purpose for special application in the Great Lakes,
for example, where there are aboriginal people just as dependent upon natural resources
as the Inuits?

Linda Birnbaum: Yes you people are much more familiar -- I know there is a Great Lakes
Initiative where you are looking at levels, for example, for certain Indian tribes and certain
subsistence sherman. In New York State, they are looking at the Akwesasne tribe of
Mohawk Indians, and trying to determine levels, but I don t think their levels are turning
out to be higher than that of other people. The reason that the Inuits levels are so high is
because they eat sea mammals, and they eat blubber, and I think there have been some
comparisons done with the Cree, who live in the same area, but they don t eat sea mam-

mals. They eat caribou and stuff like that, and their levels are not elevated. But I think we
are going to have questions of what does it mean to be elevated. Is two-fold enough? I
don t know the answer to that.
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But, if someone would say to me what is a great big research need? I would say that we
need to develop some sort of better way to do biomonitoring, because right now it costs

$2,500 per sample to measure dioxins, furans and PCB levels. Well, you can t do a lot of

samples and that is going to rapidly deplete everyone s resources. We need to develop
some sort of methodology where we can get a measure which will be much more sensitive,
and much more cost effective, so that we can get a better handle on do we have
populations where exposure is much higher than the general population.

Doug Dodge:

Things like the neurogenesis could be racially different, could it not, so you look

at different groups of people, you could get different effect levels.

Linda Birnbaum: I think that is an absolute possibility. When you deal with something like
immunotoxicity, clearly it is a multi-genic factor. Many things feed into how the immune

system works -- it is very easy to tickle it. I guess the Taiwanese data I find very important
because they do have people who are ethnically matched, but didn t eat the rice oil. Much
of the rice oil was eaten in a very limited province and at a school in that province so they

really do have pretty good match controls there, where that wouldn t really be much of a

problem. I think it is a problem with the Inuit study to find the appropriate controls. The

Cree, although they have a similar environment today in terms of their housing and so on,
are ethnically different.

Doug Dodge: I ask this question because some policy makers in the Ontario Ministry of Natural
Resources are under pressure from aboriginal people to provide them with a selected
cleaner source of native, aboriginal-type foods and they are in special situations, because
they have different reactions and we have been using the white man as the mode of
subsistence.

Linda Birnbaum: There is no doubt, for example, that many aboriginal peoples diet is very
different from the average white American or Canadian diet. At our first public meeting

we had a chief from some tribe out west in Oregon, and basically said that the amount of

fish that his people ate were at least 10 times what the U.S. Food and Drug Administration (U.S. FDA) estimates for fish consumption. So that obviously is going to have a major
impact on what the exposure is and, very frankly, the exposure information is very limited.
There has been only one market basket, and it wasn t even a complete basket study done
in the entire U.S. There have been one or two done in Canada, so there are some really big
holes.
Thank you.
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